James X Zhang1, David O Meltzer1. 1. Section of Hospital Medicine, Department of Medicine (J.X.Z., D.O.M.); Department of Economics (D.O.M.); and the Harris School of Public Policy (D.O.M.); The University of Chicago.
Abstract
CONTEXT: Access barriers to effective medication treatment have been a persistent issue for millions of older Americans despite the establishment of Medicare Part D. OBJECTIVE: We aimed to assess the prevalence rate of cost-related medication non-adherence (CRN) and the patterns of CRN behaviors in Medicare-Medicaid dual eligibles with diabetes. DESIGN SETTING PATIENTS INTERVENTIONS AND MAIN OUTCOME MEASURES: We used data from the 2011 Medicare Current Beneficiary Survey, a nationally representative sample of Medicare beneficiaries. Multivariate logistic regression analysis was performed to assess CRN rate, controlling for demographics and types of Medicare Part D plans. RESULTS: The CRN rate in dual-eligible diabetes patients was 21%, compared to 16% in non-dual-eligible diabetes patients (p<0.01). In 2011, the standardized prevalence rate of CRN in dual-eligible diabetes patients was 21%, of those with CRN 29% reported three or more types of CRN behaviors. CONCLUSION: Contrary to the common belief that dual eligibles have better insurance coverage for medication due to the assistance from Medicaid to pay some of the out-of-pocket payments, the CRN rate among dual eligibles is high and patients often report multiple types of CRN behaviors. This demonstrates that cost is a significant access barrier for dual-eligible diabetes patients. More research is needed to improve the insurance benefit design and expand insurance coverage for this high-need, high-cost subpopulation.
CONTEXT: Access barriers to effective medication treatment have been a persistent issue for millions of older Americans despite the establishment of Medicare Part D. OBJECTIVE: We aimed to assess the prevalence rate of cost-related medication non-adherence (CRN) and the patterns of CRN behaviors in Medicare-Medicaid dual eligibles with diabetes. DESIGN SETTING PATIENTS INTERVENTIONS AND MAIN OUTCOME MEASURES: We used data from the 2011 Medicare Current Beneficiary Survey, a nationally representative sample of Medicare beneficiaries. Multivariate logistic regression analysis was performed to assess CRN rate, controlling for demographics and types of Medicare Part D plans. RESULTS: The CRN rate in dual-eligible diabetespatients was 21%, compared to 16% in non-dual-eligible diabetespatients (p<0.01). In 2011, the standardized prevalence rate of CRN in dual-eligible diabetespatients was 21%, of those with CRN 29% reported three or more types of CRN behaviors. CONCLUSION: Contrary to the common belief that dual eligibles have better insurance coverage for medication due to the assistance from Medicaid to pay some of the out-of-pocket payments, the CRN rate among dual eligibles is high and patients often report multiple types of CRN behaviors. This demonstrates that cost is a significant access barrier for dual-eligible diabetespatients. More research is needed to improve the insurance benefit design and expand insurance coverage for this high-need, high-cost subpopulation.
Authors: Chien-Wen Tseng; Edward F Tierney; Robert B Gerzoff; R Adams Dudley; Beth Waitzfelder; Ronald T Ackermann; Andrew J Karter; John Piette; Jesse C Crosson; Quyen Ngo-Metzger; Richard Chung; Carol M Mangione Journal: Diabetes Care Date: 2007-11-13 Impact factor: 19.112
Authors: Farrah Nekui; Alison A Galbraith; Becky A Briesacher; Fang Zhang; Stephen B Soumerai; Dennis Ross-Degnan; Jerry H Gurwitz; Jeanne M Madden Journal: Med Care Date: 2021-01 Impact factor: 3.178
Authors: N Loren Oh; Andrew J Potter; Lindsay M Sabik; Amal N Trivedi; Fredric Wolinsky; Brad Wright Journal: BMC Health Serv Res Date: 2022-07-19 Impact factor: 2.908
Authors: Charlotte Rastas; Drew Bunker; Vikas Gampa; John Gaudet; Shirin Karimi; Ariel Majidi; Gaurab Basu; Adam Gaffney; Danny McCormick Journal: J Gen Intern Med Date: 2021-07-29 Impact factor: 6.473